In this episode of TWIRx, we break down H.R. 1 — The One Big Beautiful Bill Act — and what it could mean for the future of pharmacy in America. From PBM reform and drug pricing transparency to Medicaid restructuring and NADAC expansion, this bill carries enormous implications for community pharmacy, behavioral health services, and specialty care.
Joining us to unpack the real-world impact of this legislation are two influential voices in the pharmacy space:
- Ryan Paul Liabenow, CEO of Mango Health, a behavioral health specialty pharmacy redefining care models for patients with complex mental health needs. Ryan shares insight into how fairer reimbursement models and drug cost transparency could unlock new clinical and economic opportunities for pharmacies serving vulnerable populations.
- Nicolle McClure, President & CEO of GRx Marketing, marks her 15-year milestone as one of the most respected voices in independent pharmacy marketing. Nicolle discusses how pharmacy communication must evolve in this new legislative landscape—and why strategic messaging, patient education, and digital storytelling are now more critical than ever.
We also explore the potential challenges H.R. 1 brings, including the administrative burden of NADAC compliance and the tension between progressive pharmacy reforms and simultaneous Medicaid restrictions. Will increased oversight and transparency finally tip the scale in favor of independent pharmacies—or will coverage erosion undercut the gains?
Don’t miss this timely discussion on what may be the most consequential pharmacy bill in decades—and how forward-thinking pharmacy leaders are preparing for what's next.
sponsored by IPCRx.com